Puma Biotechnology | 营业费用





营业费用 更改 日
Agios Pharmaceuticals USD 129.75M 9.76M 2025-09
Alnylam Pharmaceuticals USD 881.04M 91.16M 2025-09
Amgen USD 5.9B 773M 2025-12
Biogen USD 1.88B 81.4M 2025-09
BioMarin Pharmaceutical USD 807.82M 259.3M 2025-09
Daiichi Sankyo JPY 468.57B 15.34B 2025-12
Esperion Therapeutics USD 67.66M 3.6M 2024-09
Exelixis USD 362.75M 21.35M 2025-12
Gilead Sciences USD 4.26B 95M 2025-09
Glaxosmithkline GBP 7.77B 2.22B 2025-09
Incyte USD 1.12B 3.53B 2025-12
MacroGenics USD 67M 8M 2025-09
Moderna USD 1.28B 232M 2025-09
Novartis USD 9.86B 115M 2025-09
Pfizer USD 12.91B 79.89B 2025-12
PTC Therapeutics USD 207.52M 6.21M 2025-09
Puma Biotechnology USD 49.26M 3.2M 2024-06
Regeneron Pharmaceuticals USD 2.99B 27.97B 2025-12
Roche Holding CHF 21.01B 10.84B 2025-12
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Sarepta Therapeutics USD 462.23M 33.28M 2025-09
Takeda JPY 1.02T 400.98B 2025-12
TG Therapeutics USD 132.34M 26.04M 2025-09
Ultragenyx Pharmaceutical USD 330.82M 56.44M 2025-09
Vanda Pharmaceuticals USD 466M 20.33M 2025-09
Vertex Pharmaceuticals USD 1.84B 27.1M 2025-09


Puma Biotechnology 营业费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.